Introduction There is still no definite drug for acute respiratory distress syndrome (ARDS)
that is capable of reducing either short-term or long-term mortality. Therefore, great efforts …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

The acute respiratory distress syndrome (ARDS) is a clinical syndrome with primarily
supportive management options. Despite extensive basic and clinical investigations …

Pharmacological treatments for acute respiratory distress sy... : Current Opinion in Critical Care
Pharmacological treatments for acute respiratory distress syndrome : Current Opinion in …

Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …

Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

Introduction Ventilatory management and general supportive care of acute respiratory
distress syndrome (ARDS) in the adult population have led to significant clinical …

Objective: To review the pathophysiology, epidemiology, and therapy of patients with acute
respiratory distress syndrome (ARDS). Data Sources: Articles pertaining to the …

312 Tuberc Respir Dis 2017; 80: 311-312 www. e-trd. org als. Effective pharmacotherapy for
ARDS remains extremely limited. Despite decades of clinical trials, no pharmacological …

Acute respiratory distress syndrome (ARDS) remains a common complication associated
with significant negative outcomes in critically ill patients. Lung-protective mechanical …